Xiaozhang Zheng

USPTO Granted Patents = 105 (Patent Applications = 47)

CIPO Patents = 6 (Patent Applications = 13)

EPO Patents = 11 (Patent Applications = 42)

Average Co-Inventor Count = 7.3

ph-index = 17

Forward Citations = 1,014(Granted Patents)

Forward Citations (Not Self Cited) = 286(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Branford, CT (US) (2003 - 2012)
Watertown, MA (US) (2015 - 2024)
Lexington, MA (US) (2017 - 2024)

Company Filing History:

43 out of 125

Forma Therapeutics, Inc.

Kymera Therapeutics, Inc.

Valo Early Discovery, Inc.

patents

8. 4 out of 88

Novo Nordisk Healthcare Ag

patents

9. 1 out of 290

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

10. 4 out of 832,761

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Nampt Inhibition

Hdac Inhibitors

Irak Degraders

Pyruvate Kinase Activators

Sickle Cell Disease Treatment

Mdm2 Degraders

Fatty Acid Synthase Inhibition

Bicyclic Hydroxamic Acids

Isoindolines

Piperidine Derivatives

Amido Derivatives

Crystalline Compounds

105 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12336981 - Compounds and compositions for the inhibition of NAMPT (2025-06-24),

2. 12304904 - Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors (2025-05-20),

3. 12264137 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2025-04-01),

4. 12258341 - IRAK degraders and uses thereof (2025-03-25),

5. 12213969 - 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors (2025-02-04),

6. 12150995 - IRAK degraders and uses thereof (2024-11-26),

7. 12122778 - Activating pyruvate kinase R (2024-10-22),

8. 12097261 - CDK2 degraders and uses thereof (2024-09-24),

9. 12091411 - IRAK degraders and uses thereof (2024-09-17),

10. 12071440 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2024-08-27),

11. 12053458 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-08-06),

12. 11980611 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-05-14),

13. 11932624 - MDM2 degraders and uses thereof (2024-03-19),

14. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2024-03-05),

15. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2024-02-06),

Title: Xiaozhang Zheng: A Visionary Innovator Shaping the Future

Introduction: Xiaozhang Zheng, a prolific inventor based in Lexington, MA (US), has made significant contributions to the world of innovation with his passion for creating solutions that shape the future. With 93 patents to his name, Zheng's relentless pursuit of excellence continues to inspire the next generation of innovators.

Latest Patents: Among his latest inventions are "MDM2 degraders and uses thereof," which provide compounds, compositions, and methods for various applications. Additionally, Zheng's "Alpha-cinnamide compounds and compositions as HDAC8 inhibitors" have shown promise in the treatment of cancer and other diseases, highlighting his versatility in addressing diverse challenges.

Career Highlights: Zheng has lent his expertise to renowned companies such as Forma Therapeutics, Inc., and Valo Health, Inc., where his innovative thinking and problem-solving skills have been instrumental in driving groundbreaking research and development initiatives. His dedication to pushing the boundaries of science and technology has earned him a reputation as a visionary leader in the field.

Collaborations: Throughout his illustrious career, Zheng has collaborated with esteemed colleagues such as Bingsong Han and David R Lancia, Jr., fostering a culture of teamwork and innovation. These partnerships have been instrumental in advancing cutting-edge projects and bringing transformative ideas to fruition.

Conclusion: Xiaozhang Zheng's unwavering commitment to innovation and his remarkable track record of inventions underscore his status as a prominent figure in the world of inventors. His pioneering spirit and dedication to creating impactful solutions continue to shape the landscape of future technologies, leaving a lasting legacy for generations to come.

This text is generated by artificial intelligence and may not be accurate.